Tirzepatide improves outcomes in patients with obesity-related HFpEF regardless of the severity of their baseline BMI or fat ...

Costa Rica: A recent systematic review published in the Cureus Journal of Medical Science has shed light on the potential of ...

Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on ...

Patients regain weight after stopping weight loss drugs, long-term success may depend on lifestyle and drug choice.

Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...

Willingness to try new drugs for obesity management have propelled the growth of this market, which today is almost five ...

It isn't easy finding high-yield dividend growth stocks when the market is at an all-time high. Shares of Novo Nordisk and ...

Patients put on weight loss drugs like Ozempic and Wegovy may start regaining weight within weeks of discontinuing them, a ...

While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...

Doctors around the world have been hailing "miracle" medications that make weight loss far easier, but new research suggests ...

Morrisons has launched its own £129-a month fat jab club leaving many shoppers unimpressed as they criticised it for selling ...

A new report from The Center for Medicine in the Public Interest (CMPI) warns that regulators are failing to stop the illegal ...